GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avacta Group PLC (OTCPK:AVCTF) » Definitions » Degree of Operating Leverage

AVCTF (Avacta Group) Degree of Operating Leverage : -1.48 (As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Avacta Group Degree of Operating Leverage?

Degree of Operating Leverage (DOL) measures the percentage change in EBIT for a unit change in Revenue. Avacta Group's Degree of Operating Leverage for the quarter that ended in Jun. 2024 was -1.48. The higher Degree of Operating Leverage, the higher operating risk the company will take.

The industry rank for Avacta Group's Degree of Operating Leverage or its related term are showing as below:

AVCTF's Degree of Operating Leverage is ranked better than
76.12% of 892 companies
in the Biotechnology industry
Industry Median: -0.075 vs AVCTF: -1.48

Avacta Group Degree of Operating Leverage Historical Data

The historical data trend for Avacta Group's Degree of Operating Leverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avacta Group Degree of Operating Leverage Chart

Avacta Group Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Dec20 Dec21 Dec22 Dec23
Degree of Operating Leverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.48 - 1.49 0.15 -0.48

Avacta Group Semi-Annual Data
Jan14 Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Degree of Operating Leverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.15 0.22 -0.48 -1.48

Competitive Comparison of Avacta Group's Degree of Operating Leverage

For the Biotechnology subindustry, Avacta Group's Degree of Operating Leverage, along with its competitors' market caps and Degree of Operating Leverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avacta Group's Degree of Operating Leverage Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avacta Group's Degree of Operating Leverage distribution charts can be found below:

* The bar in red indicates where Avacta Group's Degree of Operating Leverage falls into.


;
;

Avacta Group Degree of Operating Leverage Calculation

Avacta Group's Degree of Operating Leverage for the quarter that ended in Jun. 2024 is calculated as:

Degree of Operating Leverage=% Change in EBIT**/% Change in Revenue
=( -17.486 (Jun. 2024) / -43.124 (Jun. 2023) - 1 )/( 28.704 (Jun. 2024) / 20.049 (Jun. 2023) - 1 )
=-0.5945/0.4317
=-1.38***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of EBIT and Revenue was used to calculate Degree of Operating Leverage.
*** Please be aware that the Degree of Operating Leverage calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Avacta Group  (OTCPK:AVCTF) Degree of Operating Leverage Explanation

Degree of Operating Leverage (DOL) is a leverage ratio that measures the sensitivity of a company’s operting income, also referred to as Earnings Before Interest and Taxes (EBIT), to fluctuations in its Revenue. DOL is a method used to quantify a company’s operating risk. This risk is related to the company's structure of variable costs and fixed costs. Since the fixed costs do not allow the company to adjust the operating costs, the operating risk rises with a higher fixed-to-variable costs proportion.

A high Degree of Operating Leverage indicates that the company’s fixed costs exceed its variable costs. By increasing the sales, the company can earn more profits. In addition, the company must be able to maintain relatively high sales to cover all fixed costs.

Be Aware

The use of operating leverage varies across different industries and business sectors, and the application of Degree of Operating Leverage (DOL) should be adjusted accordingly.


Avacta Group Degree of Operating Leverage Related Terms

Thank you for viewing the detailed overview of Avacta Group's Degree of Operating Leverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Avacta Group Business Description

Traded in Other Exchanges
Address
Unit 20, Ash Way, Thorp Arch Estate, West Yorkshire, Wetherby, GBR, LS23 7FA
Avacta Group PLC is a United Kingdom-based biotechnology company. The company offers its products through three segments that are Diagnostics, Therapeutics, and Animal Health. The company is developing novel cancer immunotherapies combining its two proprietary platforms Affimer biotherapeutics and precision tumor-targeted chemotherapy. The company operates in the United Kingdom, France, South Korea, Rest of Europe, Asia, and North America.

Avacta Group Headlines

From GuruFocus

Avacta Announces Collaboration Agreement With Bruker

By Business Wire Business Wire 01-28-2021

Avacta Expands Rapid SARS-CoV-2 Antigen Test Manufacturing Capacity

By Business Wire Business Wire 09-02-2020

Avacta and Mologic Announce Commercial Partnership

By Business Wire Business Wire 02-08-2021

Avacta's Diagnostic Division Achieves ISO 13485 Certification

By Business Wire Business Wire 07-14-2021

Avacta and LG Chem Life Sciences Expand Partnership

By Business Wire Business Wire 08-18-2020